Endogenex Revenue and Competitors
Estimated Revenue & Valuation
- Endogenex's estimated annual revenue is currently $9.5M per year.
- Endogenex's estimated revenue per employee is $305,548
- Endogenex's total funding is $140M.
Employee Data
- Endogenex has 31 Employees.
- Endogenex grew their employee count by 7% last year.
Endogenex's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | Chief Medical Officer | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | VP Clinical Affairs | Reveal Email/Phone |
7 | VP, Regulatory and Quality at Endogenex | Reveal Email/Phone |
8 | VP, R&D and Operations | Reveal Email/Phone |
9 | VP Market Development | Reveal Email/Phone |
10 | Director, Quality Assurance and Operations | Reveal Email/Phone |
Endogenex Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.2M | 15 | 0% | N/A | N/A |
#2 | $1.3M | 17 | 13% | N/A | N/A |
#3 | $1M | 12 | -8% | N/A | N/A |
#4 | $9M | 29 | 16% | $33M | N/A |
#5 | $28.2M | 74 | 19% | N/A | N/A |
#6 | $1.7M | 51 | 50% | $30.3M | N/A |
#7 | $121.2M | 255 | 23% | N/A | N/A |
#8 | $26.9M | 71 | -15% | N/A | N/A |
#9 | $604.4M | 1134 | 14% | N/A | N/A |
#10 | $1.7M | 7 | 0% | N/A | N/A |
What Is Endogenex?
Endogenex, in partnership with Mayo Clinic, aims to revolutionize treatment options for individuals with type 2 diabetes (T2D). Endogenex’s innovations focus on resetting the body’s metabolic signaling system by harnessing its natural regenerative capabilities to improve metabolic function. Through the development of the ReCET System and the novel application of precise, controlled, non-thermal pulsed electric fields, Endogenex is establishing a new era in treatment options for people living with T2D, helping patients regain control of their blood glucose levels and slow disease progression.\nEndogenex is a privately held, clinical-stage company based in Minneapolis, MN.
keywords:N/A
$140M
Total Funding
31
Number of Employees
$9.5M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in PLYMOUTH
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.2M | 31 | 19% | N/A |
#2 | $5M | 31 | 933% | N/A |
#3 | $7.2M | 31 | -11% | N/A |
#4 | $8.2M | 31 | -6% | N/A |
#5 | $8M | 31 | 0% | N/A |